Clinical trials - Press Releases

Date	Title	Company
08-Jun-2023	AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology	AARDEX
07-Jun-2023	Amolyt Pharma to Host Hybrid Key Opinion Leader Event on Eneboparatide, a PTHR1 Agonist Entering Phase 3 for the Treatment of Hypoparathyroidism, in Chicago on June 16, 2023	Amolyt Pharma
07-Jun-2023	Connecta Therapeutics starts clinical trials for its Fragile X syndrome drug	Connecta Therapeutics
07-Jun-2023	Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden	Mural Health
06-Jun-2023	Phastar Statistics Manager Wins Prestigious DIA Award	Phastar
06-Jun-2023	Veeva Business Consulting Expands with New R&D Services	Veeva Systems
02-Jun-2023	Cytovation raises $8 million in Series A extension financing round for clinical advancement of CyPep-1, a first-in-class targeted tumor membrane immunotherapy	Cytovation ASA
31-May-2023	Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral adrenoleukodystrophy	Minoryx Therapeutics
31-May-2023	Enterome announces sustained positive clinical outcomes with EO2401, its lead OncoMimics™ immunotherapy, in combination therapy in Glioblastoma at ASCO	Enterome
31-May-2023	Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b	Coave Therapeutics
31-May-2023	Lotus Clinical Research Expands Partnership with Veeva to Accelerate Clinical Trials	Lotus Clinical Research
31-May-2023	Cmed and Larix fully integrated into Aixial Group, the CRO solution of ALTEN Group	Aixial Group
31-May-2023	Positive Phase 2 data of novel investigational anti-CD40L antibody frexalimab show significantly reduced disease activity in relapsing multiple sclerosis	Sanofi
31-May-2023	Avance Clinical at ASCO & BIO 2023: Early Phase Oncology Trials Increasingly Elaborate and Demand More Patients	Avance Clinical
30-May-2023	Parkinson’s AI proves accuracy in clinical studies	PD Neurotechnology
30-May-2023	MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular Dystrophy	MetrioPharm AG
30-May-2023	selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis	selectION, Inc.
26-May-2023	Avance Clinical Joins Global Heath Summit Campaign for Faster Access to Life-Changing and Life-Saving Therapies	Avance Clinical
25-May-2023	Antabio Announces First Subjects Dosed in Phase 1 Clinical Trial of MEM-ANT3310, a Highly Differentiated Antibiotic for Severe Hospital Infections	Antabio
25-May-2023	CellProthera enters final recruitment stage for phase I/IIb post-myocardial infarction therapy study	CellProthera